Wisconsin Physician Receives National Appointment to Alzheimer’s Foundation of America’s Medical, Scientific and Memory Screening Advisory Board
Dr. Nathaniel Chin is the Medical Director for the Wisconsin Alzheimer’s Disease Research Center (ADRC)
(May 4, 2021)— The Alzheimer’s Foundation of America (AFA) announced the appointment of Nathaniel Chin, M.D. to its Medical, Scientific and Memory Screening Advisory Board—a national panel of leading experts in the care, research and treatment of Alzheimer’s disease and other dementia-related illnesses. Dr. Chin is the Medical Director for the Wisconsin Alzheimer’s Disease Research Center (ADRC) and the Wisconsin Registry for Alzheimer’s Prevention (WRAP) Study, as well as the Associate Director of the Geriatric Memory Program, University of Wisconsin Hospital and Clinics.
Dr. Chin brings a wealth of professional and personal experience to his new position. He was driven to pursue a career as a geriatrician and scientist focused on dementia after his father was diagnosed with Alzheimer’s disease.
“Dr. Nathaniel Chin understands Alzheimer’s disease from a medical and scientific standpoint, but also as a family member caring for a loved one with Alzheimer’s disease. Having that unique perspective and background makes him a tremendous asset to our Medical, Scientific and Memory Screening Advisory Board,” said AFA President & CEO Charles J. Fuschillo, Jr. “We are very excited to have him as part of our team and congratulate him on earning this well-deserved appointment.”
Dr. Chin said, “I’m honored to be selected for this Board and by such a dedicated organization as the Alzheimer’s Foundation of America. The intersection of care and research is an important one, with caring for our fellow person being the foundation of what we do and research being one of the key ways of doing it right. I look forward to my time with the AFA and working toward both care and cure.”
Dr. Chin grew up in Watertown, Wisconsin, and earned undergraduate and medical degrees from the University of Wisconsin-Madison. While completing his internal medicine residency at the University of California-San Diego, Dr. Chin’s father was diagnosed Alzheimer’s disease at an early age. His father’s condition influenced the way he began to look at his own career, and Dr. Chin decided to pursue a career as a geriatrician and scientist focused on dementia, specifically Alzheimer’s disease.
In addition to seeing patients in the UW Health Memory Clinic, Dr. Chin studies modifiable risk factors and biomarker disclosure within the Wisconsin ADRC and WRAP study. He collaborates with many of the researchers at the Wisconsin ADRC and oversees the clinical care provided to the research participants. His memory clinic focuses on creating a dementia care pathway, designed to help those with cognitive impairment navigate and best utilize the health care system by aligning patient goals with medical care.
AFA is a national non-profit organization, with more than 2,000 member organizations nationwide, whose mission is to provide support, services and education to individuals, families and caregivers affected by Alzheimer’s disease and related dementias nationwide, and fund research for better treatment and a cure. Individuals who have questions about Alzheimer’s disease or need support services can contact AFA at 866-232-8484 or through its website, www.alzfdn.org.
Learn more about AFA’s Medical, Scientific and Memory Screening Advisory Board here.
